Clinical observation of moxibustion with seed-sized moxa cone combined with traditional Chinese and Western medicine in the treatment of senile acute
Early Phase 1
- Conditions
- Senile acute myeloid leukemia
- Registration Number
- ITMCTR2023000041
- Lead Sponsor
- Xi Yuan Hospital of China Academy of Chinese Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) Patients who meet the diagnostic criteria for AML;
(2)Patients over the age of 60
(3) The patient was generally in good condition, with a KPS score of 60;
(4) Patients admitted to the hospital for chemotherapy;
(5) The expected survival period is greater than 3 months;
(6) The patient participated voluntarily and signed an informed consent form.
Exclusion Criteria
(1) Patients with central nervous system leukemia;
(2) Patients with platelet count less than 10109 / L;
(3) Skin damage and other reasons are not suitable for moxibustion;
(4) With severe organ function injury and other complications, it cannot tolerate chemotherapy;
(5) Mental abnormalities and other circumstances can not cooperate.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Peripheral white blood cell count;
- Secondary Outcome Measures
Name Time Method Peripheral blood neutrophils\platelet\hemoglobin;Coagulation function\c-reactive protein;Interval and rate of rechemotherapy;Major symptom score;Amount of blood transfused during treatment (including red cell suspension and platelet collection);Percentage of bone marrow original cells;Incidence of infection and bleeding (urinary, digestive, oral, nasal) in patients during chemotherapy;KarnofskyPerformance Status;Bone marrow original cell count;